127 related articles for article (PubMed ID: 24762556)
1. Taurolidine specifically inhibits growth of neuroblastoma cell lines in vitro.
Luckert C; Eschenburg G; Roth B; Appl B; Reinshagen K; Bergholz R
J Pediatr Hematol Oncol; 2014 May; 36(4):e219-23. PubMed ID: 24762556
[TBL] [Abstract][Full Text] [Related]
2. The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma.
Nici L; Monfils B; Calabresi P
Clin Cancer Res; 2004 Nov; 10(22):7655-61. PubMed ID: 15569998
[TBL] [Abstract][Full Text] [Related]
3. Dual functionality of the antimicrobial agent taurolidine which demonstrates effective anti-tumor properties in pediatric neuroblastoma.
Swift L; Zhang C; Kovalchuk O; Boklan J; Trippett T; Narendran A
Invest New Drugs; 2020 Jun; 38(3):690-699. PubMed ID: 31264069
[TBL] [Abstract][Full Text] [Related]
4. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery.
Da Costa ML; Redmond HP; Bouchier-Hayes DJ
J Surg Res; 2001 Dec; 101(2):111-9. PubMed ID: 11735264
[TBL] [Abstract][Full Text] [Related]
5. Taurolidine: cytotoxic and mechanistic evaluation of a novel antineoplastic agent.
Calabresi P; Goulette FA; Darnowski JW
Cancer Res; 2001 Sep; 61(18):6816-21. PubMed ID: 11559556
[TBL] [Abstract][Full Text] [Related]
6. The effect of taurolidine on brain tumor cells.
Stendel R; Stoltenburg-Didinger G; Al Keikh CL; Wattrodt M; Brock M
Anticancer Res; 2002; 22(2A):809-14. PubMed ID: 12014655
[TBL] [Abstract][Full Text] [Related]
7. Induction of reactive oxygen intermediates-dependent programmed cell death in human malignant ex vivo glioma cells and inhibition of the vascular endothelial growth factor production by taurolidine.
Rodak R; Kubota H; Ishihara H; Eugster HP; Könü D; Möhler H; Yonekawa Y; Frei K
J Neurosurg; 2005 Jun; 102(6):1055-68. PubMed ID: 16028765
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of Fas-ligand-mediated programmed cell death by taurolidine.
Stendel R; Scheurer L; Stoltenburg-Didinger G; Brock M; Möhler H
Anticancer Res; 2003; 23(3B):2309-14. PubMed ID: 12894508
[TBL] [Abstract][Full Text] [Related]
9. Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines.
Walters DK; Muff R; Langsam B; Gruber P; Born W; Fuchs B
Invest New Drugs; 2007 Aug; 25(4):305-12. PubMed ID: 17458504
[TBL] [Abstract][Full Text] [Related]
10. Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins.
Sun BS; Wang JH; Liu LL; Gong SL; Redmond HP
J Surg Oncol; 2007 Sep; 96(3):241-8. PubMed ID: 17469118
[TBL] [Abstract][Full Text] [Related]
11. Divergent effects of taurolidine as potential anti-neoplastic agent: inhibition of bladder carcinoma cells in vitro and promotion of bladder tumor in vivo.
Abramjuk C; Bueschges M; Schnorr J; Jung K; Staack A; Lein M
Oncol Rep; 2009 Aug; 22(2):409-14. PubMed ID: 19578784
[TBL] [Abstract][Full Text] [Related]
12. Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma.
Opitz I; Sigrist B; Hillinger S; Lardinois D; Stahel R; Weder W; Hopkins-Donaldson S
Lung Cancer; 2007 Jun; 56(3):327-36. PubMed ID: 17383050
[TBL] [Abstract][Full Text] [Related]
13. [In vitro effect of taurolidine on squamous cell carcinoma in the oral cavity].
Petrovic L; Schlegel KA; Ries J; Park J; Diebel E; Schultze-Mosgau S; Wiltfang J
Mund Kiefer Gesichtschir; 2003 Mar; 7(2):102-7. PubMed ID: 12664255
[TBL] [Abstract][Full Text] [Related]
14. Effects of TRAIL and taurolidine on apoptosis and proliferation in human rhabdomyosarcoma, leiomyosarcoma and epithelioid cell sarcoma.
Karlisch C; Harati K; Chromik AM; Bulut D; Klein-Hitpass L; Goertz O; Hirsch T; Lehnhardt M; Uhl W; Daigeler A
Int J Oncol; 2013 Mar; 42(3):945-56. PubMed ID: 23338823
[TBL] [Abstract][Full Text] [Related]
15. The effect of Taurolidine on adherent and floating subpopulations of melanoma cells.
Shrayer DP; Lukoff H; King T; Calabresi P
Anticancer Drugs; 2003 Apr; 14(4):295-303. PubMed ID: 12679734
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of cell death induction by Taurolidine in different malignant human cancer cell lines.
Chromik AM; Daigeler A; Bulut D; Flier A; May C; Harati K; Roschinsky J; Sülberg D; Ritter PR; Mittelkötter U; Hahn SA; Uhl W
J Exp Clin Cancer Res; 2010 Mar; 29(1):21. PubMed ID: 20205945
[TBL] [Abstract][Full Text] [Related]
17. Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in rats.
Nestler G; Schulz HU; Schubert D; Krüger S; Lippert H; Pross M
Surg Endosc; 2005 Feb; 19(2):280-4. PubMed ID: 15870965
[TBL] [Abstract][Full Text] [Related]
18. The tumor suppressive reagent taurolidine inhibits growth of malignant melanoma--a mouse model.
Braumann C; Jacobi CA; Rogalla S; Menenakos C; Fuehrer K; Trefzer U; Hofmann M
J Surg Res; 2007 Dec; 143(2):372-8. PubMed ID: 17612567
[TBL] [Abstract][Full Text] [Related]
19. Taurolidine inhibits tumor cell growth in vitro and in vivo.
McCourt M; Wang JH; Sookhai S; Redmond HP
Ann Surg Oncol; 2000 Oct; 7(9):685-91. PubMed ID: 11034247
[TBL] [Abstract][Full Text] [Related]
20. Influence of intraperitoneal application of taurolidine/heparin on expression of adhesion molecules and colon cancer in rats undergoing laparoscopy.
Bobrich E; Braumann C; Opitz I; Menenakos C; Kristiansen G; Jacobi CA
J Surg Res; 2007 Jan; 137(1):75-82. PubMed ID: 17109891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]